First-line treatment of BCLC 0-A HCC transplantable patients: The era of minimally invasive techniques

Christian Hobeika^{1

2}

Affiliations

¹ Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France.
² Université Paris Cité, INSERM, U1275 CAP Paris-Tech, Paris, France.

Editorial

Christian Hobeika. Liver Int. 2024 Jun.

. 2024 Jun;44(6):1283-1285.

doi: 10.1111/liv.15934.

Christian Hobeika^{1

2}

¹ Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France.
² Université Paris Cité, INSERM, U1275 CAP Paris-Tech, Paris, France.

No abstract available

References

1. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681‐693.
1. Boros et al. Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence. Liver Int. 2024. In press.
1. Guerrini GP, Gerunda GE, Montalti R, et al. Results of salvage liver transplantation. Liver Int. 2014;34(6):e96‐e104.
1. Cucchetti A, Zhong J, Berhane S, et al. The chances of hepatic resection curing hepatocellular carcinoma. J Hepatol. 2019;72:711‐717.
1. Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922‐1965.